No Detail Found!

Epigenetic modifications in hepatocellular carcinoma: A literature review

Author(s)
Taufik Sungkar Department of Internal Medicine, Faculty of Medicine, Universitas Sumatera Utara Indonesia
Darmadi Darmadi Department of Internal Medicine, Faculty of Medicine, Universitas Sumatera Utara Indonesia
Cennikon Pakpahan Department of Biomedical Science, Faculty of Medicine, Universitas Airlangga, Surabaya Indonesia
Adriansyah Lubis Department of Forensic and Medicolegal Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
Abstract
Understanding the epigenetic mechanisms has opened new avenues for the potential reversibility of epigenetic alterations and provided an opportunity to influence and control their unfavorable consequences. These findings not only aid in identifying novel targets for therapy but also enable the prediction of treatment response. Investigating epigenetics can uncover new targets for more effective therapeutic strategies and identify novel bio-markers for diagnosing HCC in the future.
Publication Details
Page(s) 514-517
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 50, Issue: 2, Year: 2025

Request the full text from PASTIC

Keywords
Epigenetic, Carcinoma, Hepatocellular, tar-geted therapy, precision oncology.
References
Singal AG,Lampertico P,Nahon P .2020 .Epidemiology and surveillance for hepatocellular carcinoma: New trends. J Hepatol, 72 : 250-61.
Bray F,Ferlay J,Soerjomataram I,Siegel RL,Torre LA,Jemal A .2018 .GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 68 : 394-424.
El-Serag HB,Rudolph KL .2007 .Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132 : 2557-76.
Larsson SC,Wolk A .2007 .Overweight, obesity, and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer, 97 : 1005-8.
Darmadi D,Ruslie RH,Pakpahan C .2022 .Association between serum midkine levels and tumor size in Indonesian hepatocellular carcinoma patients: a cross-sectional study. Romanian J Intern Med Rev Roum Med Interne, 60 : 229-34.
Darmadi D,Ruslie RH .2021 .Association between Prothrombin Induced by Vitamin K Absence-II (PIVKA-II) and Barcelona Clinic Liver Cancer (BCLC) Stage, Tumor Size, Portal Venous Thrombosis in Hepatocellular Carcinoma Patients. Sains Malays, 50 : 475-80.
Darmadi D,Ruslie RH,Pakpahan C .2020 .Vascular Endothelial Growth Factor Levels Difference among Hepatocellular Cancer Patients Based on Barcelona Clinic Liver Cancer Staging. Open Access Maced J Med Sci, 9 : 797-800.
Wahid B,Ali A,Rafique S,Idrees M .2017 .New Insights into the Epigenetics of Hepatocellular Carcinoma. BioMed Res Int, : 1609575.
Syyam A,Akbar HR,Jilkova ZM,Afzal S. .2023 .Role of Genetic and Epigenetic Modifications in the Progression of Hepatocellular Carcinoma in Chronic HCV Patients. Livers, 3 : 82-92.
Ma L,Chua MS,Andrisani O,So S. .2014 .Epigenetics in hepatocellular carcinoma: An update and future therapy perspectives. World J Gastroenterol, 20 : 333-45.
Bhat V,Srinathan S,Pasini E,Angeli M,Chen E,Baciu C .2018 .Epigenetic basis of hepatocellular carcinoma: A network-based integrative meta-analysis. World J Hepatol, 10 : 155-65.
Hama N,Totoki Y,Miura F,Tatsuno K,Saito-Adachi M,Nakamura H .2018 .Epigenetic landscape influences the liver cancer genome architecture. Nat Commun, 9 : 1643.
Calvisi DF,Ladu S,Gorden A,Farina M,Lee JS,Conner EA .2007 .Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J Clin Invest, 117 : 2713-22.
Hamilton JP .2010 .Epigenetic mechanisms involved in the pathogenesis of hepatobiliary malignancies. Epigenomics, 2 : 233-43.
Liew CT,Li HM,Lo KW,Leow CK,Chan JY,Hin LY .1999 .High frequency of p16INK4A gene alterations in hepatocellular carcinoma. Oncogene, 18 : 789-95.
Braghini MR,Lo Re O,Romito I,Fernandez-Barrena MG,Barbaro B,Pomella S .2022 .Epigenetic remodelling in human hepatocellular carcinoma. J Exp Clin Cancer Res, 41 : 107.
Zhu L,Huang F,Wan T,Xu H,Zhao Q .2018 .Overexpression of long noncoding RNA LINC00882 is associated with poor prognosis in hepatocellular carcinoma. Onco Targets Ther, 11 : 5209-17.
Kim S,Bolatkan A,Kaneko S,Ikawa N,Asada K,Komatsu M .2019 .Deregulation of the Histone Lysine-Specific Demethylase 1 Is Involved in Human Hepatocellular Carcinoma. Biomolecules, 9 : 810-7.
Zhou P,Xia J,Zhou YJ,Wan J,Li L,Bao J .2015 .Proportions of acetyl-histone-positive hepatocytes indicate the functional status and prognosis of cirrhotic patients. World J Gastroenterol, 21 : 6665-74.
Pineau P,Volinia S,McJunkin K,Marchio A,Battiston C,Terris B .2010 .-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci, 107 : 264-9.
Dong Y,Li F,Wang J,Hu J,Li Z,Gu Y .2021 .-369 inhibits Liver Cancer progression by targeting ZEB1 pathway and predicts the prognosis of HCC patients. J Cancer, 12 : 3067-76.
Wang Q,Yang X,Zhou X,Wu B,Zhu D,Jia W .2020 .-3174 promotes proliferation and inhibits apoptosis by targeting FOXO1 in hepatocellular carcinoma. Biochem Biophys Res Commun, 526 : 889-97.
Yao H,Yang Z,Lou Y,Huang J,Yang P,Jiang W,Liver Inhibits .2021 .Cancer Stem Cells Expansion via Targeting PTPN11. Front Oncol, 11 : 632976.
Xiang D,Liu Z,Wang H,Han X,Sun T,W T .2017 .Shp2 promotes liver cancer stem cell expansion by augmenting β-catenin signaling and predicts chemotherapeutic response of patients. Hepatol Baltim Md, 65 : 1566-80.
0

Citations

0

Downloads

52

Views